Market cap
₹13,211 cr
Loading the extract…
Loading the extract…
Healthcare · Pharmaceuticals
CORONA · NSE CORONA · BSE 544644
Market cap
₹13,211 cr
Price
2,160
52w high
2,270
52w low
1,337
PE
62.4
Industry PE
—
Book value
122
Dividend yield
0.46%
ROCE
33.3
ROE
29.5
Debt / equity
—
EPS
—
No description in this extract.
| Line | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Depreciation | 38 | 37 | 28 | 20 |
| Dividend Payout % | 33 | 30 | 25 | 20 |
| EPS in Rs | 30.27 | 24.43 | 14.8 | 13.89 |
| Expenses | 1,109 | 956 | 859 | 756 |
| Interest | 7 | 11 | 14 | 4 |
| Net Profit | 185 | 149 | 90 | 85 |
| OPM % | 21 | 20 | 15 |
| Line | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 13 | 10 | 9 | 9 | 9 | 10 | 10 | 9 |
| EPS in Rs | 9.83 | 7.41 | 6.75 | 8.55 | 7.55 | 5.16 | 7.35 | 7.03 |
| Expenses | 329 | 291 | 259 | 283 | 277 | 239 | 228 | 247 |
| Interest | 3 |
| Line | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|
| DIIs | 12.9 | 7.02 | 6.77 |
| FIIs | 3.63 | 2.25 | 1.84 |
| Promoters | 69 | 69 | 69 |
| Public | 14.47 | 21.75 | 22.41 |
| 14 |
| Operating Profit | 294 | 241 | 156 | 128 |
| Other Income | -9 | 6 | 5 | 7 |
| Profit before tax | 240 | 199 | 118 | 111 |
| Sales | 1,403 | 1,196 | 1,014 | 884 |
| Tax % | 23 | 25 | 24 | 23 |
| 1 |
| 2 |
| 2 |
| 2 |
| 2 |
| 2 |
| 3 |
| Net Profit | 60 | 45 | 41 | 52 | 46 | 32 | 45 | 43 |
| OPM % | 22 | 18 | 24 | 22 | 20 | 18 | 23 | 21 |
| Operating Profit | 93 | 62 | 83 | 78 | 70 | 54 | 69 | 67 |
| Other Income | 3 | 4 | -17 | 2 | 2 | 2 | 1 | 2 |
| Profit before tax | 80 | 55 | 55 | 70 | 61 | 44 | 58 | 57 |
| Raw PDF | — | — | — | — | — | — | — | — |
| Sales | 422 | 353 | 342 | 361 | 347 | 294 | 298 | 314 |
| Tax % | 25 | 17 | 25 | 25 | 24 | 28 | 23 | 25 |